Upcoming Events

New South Wales

Investment in health, life sciences and COVID-19 – the China/Australia perspective

28 May 2020

Online Webinar via Zoom

 

Investment in health, life sciences and COVID-19 – the China/Australia perspective

 

 

COVID-19 has presented many challenges but also opportunities for Australia’s health and life science sector. This timely presentation will discuss:

1. The current landscape for investing in health and life science businesses – what are the challenges and opportunities?

2. What are the M & A trends in health and life sciences?

3. Particular issues to consider in relation to the health sector and TGA regulatory due diligence

4. Issues with foreign investment in Australia in the current environment, including FIRB.

 

Webinar Details

Date: 28 May 2020

Start: 12pm

Finish: 1pm

 

Speaker - Alison Choy Flannigan, Partner, Hall & Wilcox

With over 25 years of corporate, commercial and regulatory experience, Alison has specialised in advising clients in the health, aged care, disability, life sciences and community sectors. Alison leads the Health & Community Practice at National Law firm, Hall & Wilcox.

 

Alison has advised a number of Australian-Chinese clients, Australian clients investing overseas and Chinese clients investing in Australia, including in the area of mergers and acquisitions, capital raising, corporate and commercial law and TGA and health regulatory. Alison is also on the Australia Chinese Business Council (NSW) Health & Ageing Subcommittee and the Asia Pacific Regional Forum Liaison Officer, Healthcare and Life Sciences Law Committee of the International Bar Association.

 

Her clients include public and private hospital operators and health care providers, private health insurers, biotechnology, pharmaceutical and aged care / retirement living, NDIS and not-for-profit and government clients.

 

She is the Company Secretary for the National Foundation for Medical Research and Innovation.

 

Speaker - Eugene Chen, Partner & Head of China Practice, Hall & Wilcox

Eugene specialises in capital raising, funds management, financial services licensing and anti-money laundering law.

 

Eugene services Australian and Chinese fund managers, corporate advisors, retail and commercial banks and financial institutions, institutional investors and ultra-high net worth investors and has expertise in managing large scale mergers and acquisition, joint venturing and capital raising transactions for Australian and Chinese businesses.

 

Eugene is a native mandarin speaker and heads a team of experienced bilingual legal advisors as a part of Hall & Wilcox’s China practice.

 

Eugene has more than eight years’ experience servicing Australian and Chinese clients in mergers, capital raising, property development and funds management transactions. Eugene’s key clients include large Australian funds management and corporate advisory companies, property developers, Australian and Chinese retail banks, state owned investment companies and large listed or state owned agribusinesses.

 

Eugene is recommended in The Legal 500 Asia Pacific 2020 as a 'China expert' in banking and finance.